Skip to main content
Subodh Selukar, PhD
Subodh Selukar, PhD

Subodh Selukar, PhD

Instructor, St. Jude Faculty



BS (Biostatistics and Biology) - University of North Carolina, Chapel Hill, NC
PhD (Biostatistics) - University of Washington, Seattle, WA

Research Interests

  • Design of clinical trials
  • Sequential monitoring of clinical trials
  • Survival analysis with long-term survivors
  • Composite endpoints in studies of bone marrow transplantation

Selected Publications

Morin C, Sharma A, Selukar S, Beasley G, Merlocco A, Goode C, Rai P, Towbin JA, Hankins JS, Johnson JN. Diffuse Myocardial Fibrosis Occurs in Young Patients with Sickle Cell Anemia Despite Early Disease Modifying Therapy. Blood Nov 28:blood.2022018209, 2022. doi: 10.1182/blood.2022018209 Epub ahead of print. PMID: 36441963

Gernsheimer TB, Brown SP, Triulzi DJ, Key NS, El Kassar N, Herren H, Poston JN, Boyiadzis M, Reeves BN, Selukar S, Pagano MB, Emerson S, May S. Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial. Blood Sep 15;140(11):1254-1262, 2022. doi: 10.1182/blood.2022016308 PMID: 35667085

Selukar S, Othus M. RECeUS: Ratio estimation of censored uncured subjects, a different approach for assessing cure model appropriateness in studies with long-term survivors. Stat Med Nov 25, 2022. doi: 10.1002/sim.9610. Epub ahead of print. PMID: 36433635

Sanchez JI, Shankaran V, Unger JM, Madeleine MM, Selukar S, Thompson B. Inequitable access to surveillance colonoscopy among Medicare beneficiaries with surgically resected colorectal cancer. Cancer Feb 1;127(3):412-421, 2021. doi: 10.1002/cncr.33262 PMID: 33095916

Selukar S, May S, Law D, Othus M. Stratified randomization for platform trials with differing experimental arm eligibility. Clin Trials Oct;18(5):562-569, 2021. doi: 10.1177/17407745211028872. PMID: 34420417; PMCID: PMC8478711

Last update: February 2023